Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Prince Joseph Kannankeril, Vanderbilt University
ClinicalTrials.gov Identifier:
NCT01117454
First received: May 4, 2010
Last updated: February 11, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2015
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)